Editorial: gastroesophageal reflux disease Anno 2010.
Tytgat
Gnj
G
D000863:Antacids / Q000627:therapeutic use; D001471:Barrett Esophagus / Q000150:complications / Q000453:epidemiology* / Q000628:therapy*; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000209:etiology / Q000517:prevention & control / Q000601:surgery; D005764:Gastroesophageal Reflux / Q000150:complications / Q000453:epidemiology* / Q000628:therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D008019:Life Style; D015995:Prevalence; D054328:Proton Pump Inhibitors / Q000627:therapeutic use
D000863:Antacids; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors